Jan. 7, 2024
Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly …
Jan. 6, 2024
ReCode Therapeutics, a leader in genetic medicines, is pioneering a promising avenue in the treatment of primary ciliary dyskinesia (PCD) …
Jan. 4, 2024
In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This …
Jan. 4, 2024
C4X Discovery Holdings plc (AIM: C4XD), a drug discovery company, recently announced a significant milestone in its partnership with AstraZeneca. …
Jan. 3, 2024
InVivo Biosystems, operating in the realm of CRISPR-edited animal models for biomedical research, has recently embarked on a new phase …
Jan. 3, 2024
Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated …
Dec. 28, 2023
In a significant development in the pharmaceutical industry, Bristol Myers Squibb (BMS) has announced the acquisition of RayzeBio, a company …
Dec. 26, 2023
In a recent move in the biotechnology sector, C4 Therapeutics, Inc. (C4T) has announced a collaboration with pharmaceutical giant Merck …
Dec. 26, 2023
In a new development in the field of cancer treatment, LegoChem Biosciences, Inc., a South Korean biopharmaceutical firm, has announced …
Dec. 20, 2023
Santa Cruz-based biotech company, Unnatural Products, Inc. (UNP), has recently secured a significant investment of $32 million in its Series …
Dec. 18, 2023
In a new development in the field of dermatological therapeutics, SiSaf Ltd, a biopharmaceutical company based in Guildford, UK, has …
Dec. 18, 2023
Vandria SA, a Swiss biotechnology firm specializing in mitochondrial therapeutics, recently announced a significant milestone in its journey. The company …
